医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集
▼×

感染症

Chan Zuckerberg Biohub and Chan Zuckerberg Initiative Announce First-of-its-Kind “IDseq” Platform and Service to Enable Real-time Global Disease Surveillance and Prevention

Chan Zuckerberg Biohub and Chan Zuckerberg Initiative Announce First-of-its-Kind “IDseq” Platform and Service to Enable Real-time Global Disease Surveillance and Prevention

バイオテクノロジーヘルスケア感染症病院　 TimeLine: Chan Zuckerberg Biohub and Chan Zuckerberg Global Disease Surveillance and Prevention Platform and Service to Enable Real-time

2018年10月16日

0

Sinovac Commences Legal Proceedings to Nullify Filings Bearing a Falsified Company Seal and Forged Board Member Signatures

Sinovac Commences Legal Proceedings to Nullify Filings Bearing a Falsified Company Seal and Forged Board Member Signatures

バイオテクノロジーヘルスケア感染症製薬　 TimeLine: Falsified Company Seal and Forged Board Member Sinovac Commences Legal Proceedings to Nullify

2018年10月16日

0

Sinovac Comments on Unauthorized Use of Falsified Sinovac Hong Kong’s Company Seal and Subsidiary Board Member Signatures

Sinovac Comments on Unauthorized Use of Falsified Sinovac Hong Kong’s Company Seal and Subsidiary Board Member Signatures

その他ヘルスバイオテクノロジーヘルスケアヘルス一般医療用品感染症製薬　 TimeLine: Company Seal and Subsidiary Board Member Sinovac Comments on Unauthorized Use of Falsified

2018年10月10日

0

Valneva Receives FDA Approval for Accelerated Vaccine Dosing Schedule for IXIARO®

Valneva Receives FDA Approval for Accelerated Vaccine Dosing Schedule for IXIARO®

バイオテクノロジーヘルスケア感染症製薬　 TimeLine: Valneva Receives FDA Approval for Accelerated

2018年10月05日

0

F351 Liver Fibrosis Trial Shows Positive Efficacy

F351 Liver Fibrosis Trial Shows Positive Efficacy

バイオテクノロジーヘルスケア感染症腫瘍学臨床試験製薬　 TimeLine: F351 Liver Fibrosis Trial Shows Positive Efficacy

2018年09月28日

0

MicuRx Announces Receipt of FDA’s QIDP and Fast Track Designations for Contezolid and Contezolid Acefosamil

MicuRx Announces Receipt of FDA’s QIDP and Fast Track Designations for Contezolid and Contezolid Acefosamil

バイオテクノロジーヘルスケア感染症臨床試験製薬　 TimeLine: for Contezolid and Contezolid Acefosamil MicuRx Announces Receipt of FDA's QIDP

2018年09月21日

0

盟科医药宣布Contezolid和Contezolid acefosamil获得美国FDA的QIDP和Fast Track认定

盟科医药宣布Contezolid和Contezolid acefosamil获得美国FDA的QIDP和Fast Track认定

バイオテクノロジーヘルスケア感染症臨床試験製薬　 TimeLine: 盟科医药宣布Contezolid和

2018年09月21日

0

Pierre Fabre Receives EU Approval for BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib) in Adult Patients with Advanced BRAF-Mutant Melanoma

Pierre Fabre Receives EU Approval for BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib) in Adult Patients with Advanced BRAF-Mutant Melanoma

ヘルスケア感染症腫瘍学臨床試験製薬　 TimeLine: patients with advanced BRAF-mutant melanoma Pierre Fabre Receives EU Approval for BRAFTOVI

2018年09月21日

0

AmpliPhi Biosciences Announces Updated Positive Clinical Results for its Expanded Access Program

AmpliPhi Biosciences Announces Updated Positive Clinical Results for its Expanded Access Program

バイオテクノロジーヘルスケア感染症臨床試験製薬　 TimeLine: AmpliPhi Biosciences Announces Updated Positive its Expanded Access Program

2018年09月17日

0

Meet with Selexis Scientific and Business Leaders at Several Upcoming Industry Conferences and Events

Meet with Selexis Scientific and Business Leaders at Several Upcoming Industry Conferences and Events

その他ヘルスバイオテクノロジーヘルスケアヘルス一般感染症製薬遺伝学　 TimeLine: Meet with Selexis Scientific and Business Leaders Upcoming Industry Conferences and Events

2018年09月13日

0